Literature DB >> 18808149

Structures of Trypanosoma cruzi dihydroorotate dehydrogenase complexed with substrates and products: atomic resolution insights into mechanisms of dihydroorotate oxidation and fumarate reduction.

Daniel Ken Inaoka1, Kimitoshi Sakamoto, Hironari Shimizu, Tomoo Shiba, Genji Kurisu, Takeshi Nara, Takashi Aoki, Kiyoshi Kita, Shigeharu Harada.   

Abstract

Dihydroorotate dehydrogenase (DHOD) from Trypanosoma cruzi (TcDHOD) is a member of family 1A DHOD that catalyzes the oxidation of dihydroorotate to orotate (first half-reaction) and then the reduction of fumarate to succinate (second half-reaction) in the de novo pyrimidine biosynthesis pathway. The oxidation of dihydroorotate is coupled with the reduction of FMN, and the reduced FMN converts fumarate to succinate in the second half-reaction. TcDHOD are known to be essential for survival and growth of T. cruzi and a validated drug target. The first-half reaction mechanism of the family 1A DHOD from Lactococcus lactis has been extensively investigated on the basis of kinetic isotope effects, mutagenesis and X-ray structures determined for ligand-free form and in complex with orotate, the product of the first half-reaction. In this report, we present crystal structures of TcDHOD in the ligand-free form and in complexes with an inhibitor, physiological substrates and products of the first and second half-reactions. These ligands bind to the same active site of TcDHOD, which is consistent with the one-site ping-pong Bi-Bi mechanism demonstrated by kinetic studies for family 1A DHODs. The binding of ligands to TcDHOD does not cause any significant structural changes to TcDHOD, and both reduced and oxidized FMN cofactors are in planar conformation, which indicates that the reduction of the FMN cofactor with dihydroorotate produces anionic reduced FMN. Therefore, they should be good models for the enzymatic reaction pathway of TcDHOD, although orotate and fumarate bind to TcDHOD with the oxidized FMN and dihydroorotate with the reduced FMN in the structures determined here. Cys130, which was identified as the active site base for family 1A DHOD (Fagan, R. L., Jensen, K. F., Bjornberg, O., and Palfey, B. A. (2007) Biochemistry 46, 4028-4036.), is well located for abstracting a proton from dihydroorotate C5 and transferring it to outside water molecules. The bound fumarate is in a twisted conformation, which induces partial charge separation represented as C 2 (delta-) and C 3 (delta+). Because of this partial charge separation, the thermodynamically favorable reduction of fumarate with reduced FMN seems to proceed in the way that C 2 (delta-) accepts a proton from Cys130 and C 3 (delta+) a hydride (or a hydride equivalent) from reduced FMN N 5 in TcDHOD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18808149     DOI: 10.1021/bi800413r

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  15 in total

1.  Recombinant production, crystallization and crystal structure determination of dihydroorotate dehydrogenase from Leishmania (Viannia) braziliensis.

Authors:  Renata Almeida Garcia Reis; Eder Lorenzato; Valeria Cristina Silva; Maria Cristina Nonato
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2015-04-21       Impact factor: 1.056

2.  Disruption of the proton relay network in the class 2 dihydroorotate dehydrogenase from Escherichia coli.

Authors:  Rebecca L Kow; Jonathan R Whicher; Claudia A McDonald; Bruce A Palfey; Rebecca L Fagan
Journal:  Biochemistry       Date:  2009-10-20       Impact factor: 3.162

3.  Roles in binding and chemistry for conserved active site residues in the class 2 dihydroorotate dehydrogenase from Escherichia coli.

Authors:  Rebecca L Fagan; Bruce A Palfey
Journal:  Biochemistry       Date:  2009-08-04       Impact factor: 3.162

4.  The unassembled flavoprotein subunits of human and bacterial complex II have impaired catalytic activity and generate only minor amounts of ROS.

Authors:  Elena Maklashina; Sany Rajagukguk; T M Iverson; Gary Cecchini
Journal:  J Biol Chem       Date:  2018-04-02       Impact factor: 5.157

5.  Crystallization of mitochondrial rhodoquinol-fumarate reductase from the parasitic nematode Ascaris suum with the specific inhibitor flutolanil.

Authors:  Arihiro Osanai; Shigeharu Harada; Kimitoshi Sakamoto; Hironari Shimizu; Daniel Ken Inaoka; Kiyoshi Kita
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-08-26

6.  Pharmacophore modeling for anti-Chagas drug design using the fragment molecular orbital method.

Authors:  Ryunosuke Yoshino; Nobuaki Yasuo; Daniel Ken Inaoka; Yohsuke Hagiwara; Kazuki Ohno; Masaya Orita; Masayuki Inoue; Tomoo Shiba; Shigeharu Harada; Teruki Honma; Emmanuel Oluwadare Balogun; Josmar Rodrigues da Rocha; Carlos Alberto Montanari; Kiyoshi Kita; Masakazu Sekijima
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240

7.  The Open Form Inducer Approach for Structure-Based Drug Design.

Authors:  Daniel Ken Inaoka; Maiko Iida; Toshiyuki Tabuchi; Teruki Honma; Nayoung Lee; Satoshi Hashimoto; Shigeru Matsuoka; Takefumi Kuranaga; Kazuhito Sato; Tomoo Shiba; Kimitoshi Sakamoto; Emmanuel Oluwadare Balogun; Shigeo Suzuki; Takeshi Nara; Josmar Rodrigues da Rocha; Carlos Alberto Montanari; Akiko Tanaka; Masayuki Inoue; Kiyoshi Kita; Shigeharu Harada
Journal:  PLoS One       Date:  2016-11-28       Impact factor: 3.240

8.  Essential multimeric enzymes in kinetoplastid parasites: A host of potentially druggable protein-protein interactions.

Authors:  Leah M Wachsmuth; Meredith G Johnson; Jason Gavenonis
Journal:  PLoS Negl Trop Dis       Date:  2017-06-29

Review 9.  Fresh insights into the pyrimidine metabolism in the trypanosomatids.

Authors:  Kartikeya Tiwari; Vikash Kumar Dubey
Journal:  Parasit Vectors       Date:  2018-02-08       Impact factor: 3.876

10.  Crystal structures of FMN-bound and FMN-free forms of dihydroorotate dehydrogenase from Trypanosoma brucei.

Authors:  Tomomi Kubota; Osamu Tani; Tomohiko Yamaguchi; Ichiji Namatame; Hitoshi Sakashita; Koji Furukawa; Kazuhiko Yamasaki
Journal:  FEBS Open Bio       Date:  2018-03-06       Impact factor: 2.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.